463 Followers on Owler

Amunix

Read more
Angie You's photo - CEO of Amunix

CEO

Angie You

CEO Approval Rating

86/100

Founded:

2006

Status:

PrivateIndependent Company

AMUNIX TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Tmunity is perceived as one of Amunix's biggest rivals. Tmunity's headquarters is in Philadelphia, Pennsylvania, and was founded in 2015. Tmunity operates in the Biotechnology industry. Tmunity generates 416% of Amunix's revenue.

TScan has been one of Amunix's top competitors. TScan is a Public company that was founded in 2018 in Waltham, Massachusetts. TScan operates in the Biotechnology industry. Compared to Amunix, TScan has NaN fewer employees.

Triumvira is Amunix's #3 rival. Triumvira was founded in Austin, Texas} in 2015. Triumvira is in the Biotechnology industry. Compared to Amunix, Triumvira generates $1.8M more revenue.

Amunix Acquisitions

No recent acquisitions found related to Amunix

Amunix Funding History

Since Amunix was founded in 2006, it has participated in 3 rounds of funding. In total Amunix has raised $230.0M. Amunix's last funding round was on Mar 2021 for a total of $117.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Mar 2021
$117M

Viking Global Investors

Series A
Mar 2020
$73M
Equity
Jan 2020
$40M

Since Amunix was founded in 2006, it has participated in 3 rounds of funding. In total Amunix has raised $230.0M. Amunix's last funding round was on Mar 2021 for a total of $117.0M

Amunix Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Versartis develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders.
$20M
Oct 08, 2013
Series D
Oct 01, 2018

These are all the companies that Amunix has invested in. Amunix's latest investment was Versartis in Oct 08,. Versartis develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders.

Amunix News

Amunix Press Releases

Social Media

Amunix Headquarters

2 Tower Pl Suite 1100

South San Francisco, California94080

650-428-1800

Driving Directions »

Trending Companies

Amunix Summary

ABOUT

Overview

Amunix is a California-based biotechnology firm that develops T cell-based biotherapeutics to treat patients with solid tumor cancers. Amunix was founded in 2006. Amunix's headquarters is located in South San Francisco, California, USA 94080. It has r...

CEO

Amunix's CEO, Angie You, currently has an approval rating of 86%. Amunix's primary competitors are Tmunity, TScan & Triumvira.

Website

amunix.com

Frequently Asked Questions about Amunix

  1. When was Amunix founded?

    Amunix was founded in 2006
  2. Who is Amunix's CEO?

    Amunix's CEO is Angie You
  3. How much revenue does Amunix generate?

    Amunix generates $1.2M in revenue
  4. How much funding does Amunix have?

    Amunix has historically raised $230M in funding
  5. Where is Amunix's headquarters?

    Amunix's headquarters is in South San Francisco California, USA
  1. How many employees does Amunix have?

    Amunix has 50 employees
  2. What sector does Amunix operate in?

    Amunix is in Pharmaceuticals, Biotechnology
  3. Who are Amunix's competitors?

    Amunix's top competitors are Tmunity, TScan, Triumvira
  4. Who has Amunix invested in?

    Amunix's has invested in companies such as Versartis